UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma

UPDATE 1-U.S. FDA approves Teva's biotech drug for severe asthma


The U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a history of severe attacks despite taking medication. The drug, Cinqair, part of a new wave of biotech drugs for severe asthma, is administered intravenously every four weeks in combination with other drugs.



from Biotech News